Direct Antiviral Agents May Obviate the Need for Liver Transplantation for HCV Cirrhosis by the End of the Decade

<b>Background:</b> Hepatitis C viral infection (HCV) has historically been a leading indication for liver transplantation (LTx), primarily due to its progression to cirrhosis and hepatocellular carcinoma (HCC). However, the advent of direct-acting antiviral agents (DAAs) over a decade ago has revolu...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Nathanael Haynes, Allyson Cochran, Maria Baimas-George, William Archie, Namratha Mylarapu, Vincent Casingal, Jose Soto, Philippe Zamor, Andrew DeLemos, Paul Schmeltzer, Steven Zacks, Natasha Adlakha, Roger Denny, Mark Russo, Lon Eskind, Dionisios Vrochides
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2026-04-01
Sarja:	Surgeries
Aiheet:	transplant hepatitis C hepatocellular carcinoma direct-acting antivirals
Linkit:	https://www.mdpi.com/2673-4095/7/2/51
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!